EIN: 311667995 · Tax Year 2023 · Source: IRS Form 990
| Metric | Amount |
|---|---|
| Total Revenue | $39.1M |
| Total Expenses | $33.6M |
| Net Income | $5.5M |
| Total Assets (End of Year) | $110.1M |
Conquer Cancer Fdn Of The American Society Of Clinical Oncology reported $39.1M in total revenue for the 2023 tax year, with $33.6M in total expenses and $110.1M in net assets.
Detailed spending breakdown data is not available for Conquer Cancer Fdn Of The American Society Of Clinical Oncology's 2023 filing.
This data comes from Conquer Cancer Fdn Of The American Society Of Clinical Oncology's IRS Form 990 filed for the 2023 tax year. Form 990 is a public document that all tax-exempt organizations must file annually with the IRS.
The IRS Form 990 is a public document that tax-exempt organizations must file annually. It provides detailed information about an organization's finances, governance, and activities. Key sections include revenue and expenses, compensation of officers, and program accomplishments.
All data shown on this page comes directly from Conquer Cancer Fdn Of The American Society Of Clinical Oncology's publicly available IRS Form 990 for the 2023 tax year. This information is provided for transparency and research purposes.